0,963  0,004  Apoptosis agonist
0,938  0,005  Antiinflammatory
0,930  0,002  Caspase 9 stimulant
0,914  0,004  Antineoplastic (lung cancer)
0,912  0,005  Transcription factor NF kappa B inhibitor
0,884  0,005  TNF expression inhibitor
0,881  0,003  Nitric oxide antagonist
0,876  0,003  Chemopreventive
0,872  0,005  Antineoplastic (breast cancer)
0,871  0,004  Antineoplastic (melanoma)
0,848  0,005  Antineoplastic (ovarian cancer)
0,827  0,001  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,828  0,003  5 Hydroxytryptamine release stimulant
0,817  0,004  Hepatic disorders treatment
0,815  0,005  Prostate cancer treatment
0,814  0,005  Antileukemic
0,813  0,004  Antineoplastic (pancreatic cancer)
0,808  0,003  Hepatoprotectant
0,799  0,002  Antineoplastic (endocrine cancer)
0,776  0,004  AR expression inhibitor
0,765  0,006  Chemoprotective
0,757  0,010  Antineoplastic (colorectal cancer)
0,748  0,005  Caspase 3 stimulant
0,753  0,009  Antidiabetic
0,753  0,009  Cyclophilin D inhibitor
0,753  0,009  Antineoplastic (colon cancer)
0,741  0,003  Protein-tyrosine phosphatase 1B inhibitor
0,722  0,005  NOS2 expression inhibitor
0,711  0,003  Protein-tyrosine phosphatase inhibitor
0,703  0,006  Antineoplastic (cervical cancer)
0,698  0,002  ICAM1 expression inhibitor
0,692  0,005  Apoptosis antagonist
0,685  0,005  Antineoplastic (multiple myeloma)
0,677  0,003  Phospholipase C inhibitor
0,668  0,005  Antineoplastic (glioma)
0,662  0,004  Insulin secretagoues
0,648  0,002  AMP-activated protein kinase stimulant
0,646  0,006  Antipyretic
0,640  0,002  Interferon gamma antagonist
0,638  0,006  Cardiodepressant
0,632  0,012  Sensitization
0,607  0,005  Antihypoxic
0,603  0,005  Vascular (periferal) disease treatment
0,604  0,011  Antioxidant
0,602  0,012  Cytotoxic
0,593  0,004  Antiviral (Influenza A)
0,592  0,009  Hypoglycemic
0,581  0,002  Contraceptive female
0,581  0,004  Antiviral (Influenza)
0,584  0,010  Antineoplastic (brain cancer)
0,575  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,567  0,005  Wound healing agent
0,571  0,013  Cardioprotectant
0,552  0,008  Antineoplastic (glioblastoma multiforme)
0,552  0,013  Antidiabetic (type 2)
0,541  0,002  Phosphorylase inhibitor
0,536  0,007  Antineoplastic (liver cancer)
0,549  0,023  Immunostimulant
0,544  0,026  Cholesterol antagonist
0,521  0,009  Antihypertriglyceridemic
0,557  0,064  Alpha-glucosidase inhibitor
0,497  0,020  NOS3 expression inhibitor
0,483  0,006  Contraceptive
0,481  0,005  Antiviral (Hepatitis B)
0,483  0,009  Antiviral (HIV)
0,478  0,011  Antineoplastic (renal cancer)
0,494  0,028  Bone diseases treatment
0,489  0,027  Antihypercholesterolemic
0,459  0,004  Cyclooxygenase 3 inhibitor
0,458  0,003  Cholesterol synthesis inhibitor
0,461  0,007  Antiviral (Hepatitis)
0,469  0,016  UGT2B4 substrate
0,456  0,010  UGT1A4 substrate
0,458  0,012  Antihelmintic
0,457  0,012  Antiulcerative
0,447  0,004  Insulin sensitizer
0,463  0,021  Antiprotozoal (Leishmania)
0,449  0,008  Prostate disorders treatment
0,465  0,026  Lipoprotein disorders treatment
0,440  0,004  Gastrin inhibitor
0,444  0,010  Abortion inducer
0,451  0,019  Antiparasitic
0,459  0,036  Antithrombotic
0,430  0,014  Transcription factor STAT3 inhibitor
0,419  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,440  0,027  Metabolic disease treatment
0,416  0,003  Inducible nitric-oxide synthase inhibitor
0,423  0,010  Prostatic (benign) hyperplasia treatment
0,416  0,004  Antihelmintic (Nematodes)
0,414  0,011  Hair growth stimulant
0,413  0,012  Antineoplastic (carcinoma)
0,447  0,048  Immunosuppressant
0,402  0,005  Antiinfertility, female
0,406  0,013  Diuretic
0,423  0,032  Antiosteoporotic
0,400  0,009  Lipid peroxidase inhibitor
0,404  0,016  Sodium/bile acid cotransporter inhibitor
0,399  0,011  Antiacne
0,433  0,046  Vasodilator, peripheral
0,401  0,019  Antineoplastic (lymphocytic leukemia)
0,406  0,026  Tumour necrosis factor alpha release inhibitor
0,387  0,008  Antiviral (Hepatitis C)
0,399  0,022  Angiogenesis stimulant
0,434  0,058  Histamine release inhibitor
0,372  0,009  Liver fibrosis treatment
0,396  0,033  Antineoplastic (non-small cell lung cancer)
0,376  0,013  Antineoplastic (squamous cell carcinoma)
0,379  0,016  Antiviral (Herpes)
0,371  0,009  Interleukin 6 antagonist
0,364  0,007  Antitussive
0,354  0,003  Transcription factor NF kappa B stimulant
0,357  0,017  UGT2B7 substrate
0,403  0,063  Atherosclerosis treatment
0,366  0,032  Hypolipemic
0,348  0,016  Skin whitener
0,350  0,019  Platelet adhesion inhibitor
0,337  0,015  Lipocortins synthesis antagonist
0,354  0,033  Transcription factor STAT inhibitor
0,367  0,051  Antipsoriatic
0,352  0,039  Proliferative diseases treatment
0,318  0,007  Antihemorrhagic
0,316  0,008  Expectorant
0,334  0,029  UDP-glucuronosyltransferase substrate
0,342  0,039  Carcinogenic
0,328  0,030  Antineoplastic (sarcoma)
0,300  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,330  0,039  Vasodilator
0,329  0,045  Renal disease treatment
0,326  0,044  Antineoplastic (lymphoma)
0,285  0,007  Anticataract
0,330  0,055  Interleukin 2 agonist
0,338  0,064  Antifungal
0,283  0,019  Protein kinase stimulant
0,261  0,003  Aldosterone antagonist
0,276  0,022  Diabetic nephropathy treatment
0,305  0,051  Free radical scavenger
0,251  0,004  Lanosterol 14 alpha demethylase inhibitor
0,268  0,023  UGT2B15 substrate
0,258  0,016  DNA polymerase I inhibitor
0,279  0,038  UGT1A1 substrate
0,304  0,065  CYP2C19 substrate
0,336  0,099  Antipruritic, allergic
0,286  0,052  Antineoplastic (bladder cancer)
0,268  0,036  P-glycoprotein inhibitor
0,246  0,014  UGT2B10 substrate
0,259  0,027  Melanin inhibitor
0,237  0,008  HDL-cholesterol increasing
0,258  0,034  Neurotrophic factor enhancer
0,232  0,010  Potassium channel (Ca-activated) activator
0,234  0,014  Antinephritic
0,237  0,024  UGT2B9 substrate
0,227  0,015  Farnesoid X receptor antagonist
0,327  0,116  Antibacterial
0,272  0,062  Myocardial infarction treatment
0,213  0,009  Adenylate cyclase stimulant
0,226  0,034  Skeletal muscle relaxant
0,252  0,060  UGT1A6 substrate
0,326  0,135  Antiarthritic
0,213  0,022  Arachidonic acid antagonist
0,303  0,114  Antiobesity
0,238  0,048  Non-steroidal antiinflammatory agent
0,191  0,002  Heme oxygenase stimulant
0,257  0,069  Cardiovascular analeptic
0,222  0,037  LDLR expression enhancer
0,326  0,144  Alzheimer's disease treatment
0,194  0,014  Androgen antagonist
0,185  0,006  Anabolic
0,224  0,047  Muscle relaxant
0,283  0,110  CYP3A4 substrate
0,185  0,011  ABCA1 expression enhancer
0,235  0,062  Antineoplastic enhancer
0,176  0,006  CC chemokine 6 receptor antagonist
0,172  0,003  Na+ K+ transporting ATPase inhibitor
0,179  0,014  Nitric-oxide synthase inhibitor
0,169  0,005  Glycine receptor antagonist
0,204  0,040  Phospholipase A2 inhibitor
0,182  0,019  Protease inhibitor
0,172  0,011  Antiprotozoal (Toxoplasma)
0,181  0,024  Beta amyloid protein antagonist
0,160  0,004  Diacylglycerol O-acyltransferase inhibitor
0,162  0,011  UGT2B11 substrate
0,196  0,046  Amylase inhibitor
0,206  0,057  Antipruritic, non-allergic
0,200  0,052  Antineoplastic (gastric cancer)
0,257  0,110  Antineoplastic (osteosarcoma)
0,153  0,007  5-Alpha-reductase inhibitor
0,151  0,007  Androgen agonist
0,170  0,028  Interleukin 1b antagonist
0,169  0,029  Microtubule formation inhibitor
0,143  0,004  RNA-directed RNA polymerase stimulant
0,148  0,016  Contraceptive male
0,160  0,028  Choleretic
0,241  0,111  Analeptic
0,142  0,012  Potassium channel large-conductance Ca-activated activator
0,141  0,011  3C-Like protease (SARS coronavirus) inhibitor
0,143  0,014  Aromatase inhibitor
0,158  0,029  Antineoplastic antibiotic
0,129  0,003  Cholesterol ester transfer protein antagonist
0,184  0,060  Antirickettsial
0,135  0,011  Bile acid receptor antagonist
0,172  0,049  Antidiabetic (type 1)
0,222  0,103  UGT1A9 substrate
0,128  0,013  Estrogen agonist
0,193  0,078  Anesthetic general
0,201  0,094  Teratogen
0,161  0,056  Anesthetic
0,108  0,004  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,109  0,009  Estradiol 17 beta-dehydrogenase inhibitor
0,145  0,045  Growth stimulant
0,230  0,131  CTGF expression inhibitor
0,102  0,008  Nitric oxide donor
0,183  0,089  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,119  0,029  Antiviral (Rhinovirus)
0,112  0,022  Lipase inhibitor
0,094  0,004  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,212  0,123  Respiratory analeptic
0,147  0,059  Psychosexual dysfunction treatment
0,093  0,005  Estrone sulfatase inhibitor
0,100  0,013  Transcription factor AP-1 inhibitor
0,091  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,103  0,017  Postmenopausal disorders treatment
0,094  0,008  Postcoital contraceptive
0,117  0,032  SULT1E1 substrate
0,127  0,042  Estrogen antagonist
0,098  0,014  Acetyl-CoA transferase inhibitor
0,089  0,008  Acetyl-CoA transferase 2 inhibitor
0,139  0,058  Liver cirrhosis treatment
0,122  0,041  Chronic obstructive bronchitis treatment
0,156  0,078  UGT1A3 substrate
0,091  0,014  SULT2A1 substrate
0,121  0,044  Sulfotransferase substrate
0,127  0,052  Topoisomerase I inhibitor
0,084  0,011  Lipocortins synthesis agonist
0,092  0,019  CDC25B inhibitor
0,227  0,157  Vasodilator, coronary
0,094  0,025  Glycine receptor agonist
0,125  0,057  Alcohol dehydrogenase substrate
0,104  0,037  Topoisomerase II alpha inhibitor
0,075  0,008  Cholesterol esterase inhibitor
0,105  0,039  Ornithine decarboxylase inhibitor
0,133  0,067  Acetylcholinesterase inhibitor
0,068  0,004  Tubulin agonist
0,170  0,106  Embryotoxic
0,089  0,025  Anticholelithogenic
0,076  0,013  CD45 antagonist
0,094  0,031  CDC25A inhibitor
0,066  0,008  Farnesoid X receptor agonist
0,067  0,010  Liver X receptor alpha agonist
0,062  0,006  Glucose-6-phosphate dehydrogenase inhibitor
0,127  0,071  Antihyperlipoproteinemic
0,110  0,056  Beta glucuronidase inhibitor
0,063  0,012  Microtubule stabilization
0,097  0,050  Actinic keratosis treatment
0,099  0,053  Uric acid excretion stimulant
0,187  0,144  Amyotrophic lateral sclerosis treatment
0,110  0,068  Monophenol monooxygenase inhibitor
0,057  0,016  Estrogen receptor alpha agonist
0,138  0,098  Growth hormone agonist
0,042  0,002  Telomerase stimulant
0,108  0,068  SULT1A1 substrate
0,058  0,018  Estrogen receptor beta agonist
0,057  0,018  Liver X receptor agonist
0,050  0,013  Heme oxygenase inhibitor
0,100  0,064  Estrogen receptor beta antagonist
0,210  0,174  GST M1-1 substrate
0,160  0,126  Antiparkinsonian, rigidity relieving
0,038  0,005  Hedgehog signaling activator
0,131  0,098  Thrombolytic
0,130  0,099  Pregnane X receptor agonist
0,036  0,005  Corticosteroid-like
0,043  0,012  HMG CoA reductase inhibitor
0,090  0,061  Glutamate release inhibitor
0,050  0,021  Parathyroid hormone antagonist
0,100  0,072  UGT2B1 substrate
0,077  0,049  SULT1A2 substrate
0,055  0,028  Anesthetic inhalation
0,125  0,101  Cholinergic
0,208  0,187  CYP2C9 substrate
0,103  0,083  Antiviral (Coronavirus)
0,103  0,083  Antiviral (SARS coronavirus)
0,077  0,058  Chymotrypsin inhibitor
0,031  0,012  1,3-Beta-glucan synthase inhibitor
0,048  0,029  Adenylate cyclase 1 inhibitor
0,101  0,085  Topoisomerase II inhibitor
0,043  0,029  Oxytocin agonist
0,022  0,009  Progesterone agonist
0,080  0,068  mTOR complex 2 inhibitor
0,035  0,025  p53 inhibitor
0,130  0,120  Ca2+-transporting ATPase inhibitor
0,017  0,010  Vitamin D receptor agonist
0,077  0,071  Thioredoxin reductase inhibitor
0,049  0,044  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,008  0,003  Transcortin receptor antagonist
0,013  0,009  Glucocorticoid agonist
0,021  0,018  Vitamin D receptor antagonist
0,018  0,016  5-Alpha-reductase 2 inhibitor
0,108  0,107  Antihelmintic (Trematoda)
0,140  0,140  Toxic, respiratory center
0,108  0,108  Interleukin 1 antagonist

